XILIARX

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Romania, Spain.

Active ingredients

The drug XILIARX contains one active pharmaceutical ingredient (API):

1
UNII I6B4B2U96P - VILDAGLIPTIN
 

Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

 
Read more about Vildagliptin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10BH02 Vildagliptin A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1391307, 1391318, 1391329, 1391330, 1391341, 1391352, 1391363, 1391374, 1391385, 1391396
ES Centro de información online de medicamentos de la AEMPS 08486003, 08486005
FR Base de données publique des médicaments 62604349
IT Agenzia del Farmaco 038999013, 038999025, 038999037, 038999049, 038999052, 038999064, 038999076, 038999088, 038999090, 038999102, 038999114
LT Valstybinė vaistų kontrolės tarnyba 1035145, 1035146, 1035147, 1035148, 1035149, 1035150, 1035151, 1035152, 1035153, 1035154, 1035155
PL Rejestru Produktów Leczniczych 100313530
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W54464001, W54464002, W54464003, W54464004, W54464005, W54464006, W54464007, W54464008, W54464009, W54464010, W54464011

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.